

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | membrane raft organization (GO:0031579) | 4.12949551 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.94343488 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.94343488 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.93078818 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.85052311 |
| 6 | desmosome organization (GO:0002934) | 3.80256494 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 3.71656664 |
| 8 | hemidesmosome assembly (GO:0031581) | 3.70114540 |
| 9 | ribosomal small subunit assembly (GO:0000028) | 3.68688901 |
| 10 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.66880733 |
| 11 | NIK/NF-kappaB signaling (GO:0038061) | 3.65868434 |
| 12 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.55839594 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.53385794 |
| 14 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.44532531 |
| 15 | sequestering of actin monomers (GO:0042989) | 3.44277500 |
| 16 | hepatocyte apoptotic process (GO:0097284) | 3.41228788 |
| 17 | regulation of metalloenzyme activity (GO:0048552) | 3.29623289 |
| 18 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.26445939 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.23995364 |
| 20 | negative regulation of cell killing (GO:0031342) | 3.23995364 |
| 21 | regulation of interleukin-8 secretion (GO:2000482) | 3.20136245 |
| 22 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.16708953 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.15920937 |
| 24 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.14636982 |
| 25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.12258497 |
| 26 | myeloid dendritic cell activation (GO:0001773) | 3.08040750 |
| 27 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.07261936 |
| 28 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.06391871 |
| 29 | interferon-gamma production (GO:0032609) | 3.06029320 |
| 30 | regulation of T cell tolerance induction (GO:0002664) | 3.02598135 |
| 31 | necroptotic process (GO:0070266) | 3.00739560 |
| 32 | myeloid dendritic cell differentiation (GO:0043011) | 2.98910291 |
| 33 | neutrophil activation (GO:0042119) | 2.97707190 |
| 34 | keratinocyte development (GO:0003334) | 2.97667894 |
| 35 | negative thymic T cell selection (GO:0045060) | 2.95670575 |
| 36 | positive regulation of isotype switching (GO:0045830) | 2.91340973 |
| 37 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.89521907 |
| 38 | negative T cell selection (GO:0043383) | 2.88050095 |
| 39 | positive regulation of interleukin-2 production (GO:0032743) | 2.86252536 |
| 40 | positive regulation of macrophage differentiation (GO:0045651) | 2.85045691 |
| 41 | granulocyte activation (GO:0036230) | 2.84742413 |
| 42 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.82643120 |
| 43 | viral transcription (GO:0019083) | 2.81122470 |
| 44 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.81082090 |
| 45 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.80386331 |
| 46 | cytidine metabolic process (GO:0046087) | 2.79837939 |
| 47 | cytidine catabolic process (GO:0006216) | 2.79837939 |
| 48 | cytidine deamination (GO:0009972) | 2.79837939 |
| 49 | actin nucleation (GO:0045010) | 2.79625904 |
| 50 | regulation of antigen processing and presentation (GO:0002577) | 2.79023423 |
| 51 | leukocyte aggregation (GO:0070486) | 2.78117930 |
| 52 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.76840771 |
| 53 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.76437924 |
| 54 | positive regulation of antigen processing and presentation (GO:0002579) | 2.73066088 |
| 55 | interferon-gamma secretion (GO:0072643) | 2.72936241 |
| 56 | response to type I interferon (GO:0034340) | 2.71927276 |
| 57 | translational termination (GO:0006415) | 2.70936064 |
| 58 | type I interferon signaling pathway (GO:0060337) | 2.70781592 |
| 59 | cellular response to type I interferon (GO:0071357) | 2.70781592 |
| 60 | dendritic cell chemotaxis (GO:0002407) | 2.69614428 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 2.69543273 |
| 62 | response to interferon-beta (GO:0035456) | 2.68967680 |
| 63 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.64516911 |
| 64 | regulation of RIG-I signaling pathway (GO:0039535) | 2.64358805 |
| 65 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.63663544 |
| 66 | positive regulation of interferon-alpha production (GO:0032727) | 2.62241883 |
| 67 | positive regulation of interleukin-12 production (GO:0032735) | 2.61310759 |
| 68 | regulation of regulatory T cell differentiation (GO:0045589) | 2.61022140 |
| 69 | response to muramyl dipeptide (GO:0032495) | 2.60930914 |
| 70 | cellular response to interferon-beta (GO:0035458) | 2.60852397 |
| 71 | intestinal epithelial cell development (GO:0060576) | 2.59972866 |
| 72 | response to protozoan (GO:0001562) | 2.59271341 |
| 73 | natural killer cell mediated immunity (GO:0002228) | 2.56769280 |
| 74 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.56769280 |
| 75 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.55670460 |
| 76 | protein targeting to ER (GO:0045047) | 2.55279674 |
| 77 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54851342 |
| 78 | dendritic cell migration (GO:0036336) | 2.54787377 |
| 79 | dendritic cell differentiation (GO:0097028) | 2.54763907 |
| 80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.54369444 |
| 81 | response to interleukin-15 (GO:0070672) | 2.54325450 |
| 82 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.53946628 |
| 83 | regulation of natural killer cell differentiation (GO:0032823) | 2.53639240 |
| 84 | cotranslational protein targeting to membrane (GO:0006613) | 2.53306970 |
| 85 | response to peptidoglycan (GO:0032494) | 2.52136054 |
| 86 | natural killer cell activation (GO:0030101) | 2.52000605 |
| 87 | positive regulation of DNA recombination (GO:0045911) | 2.51970489 |
| 88 | defense response to protozoan (GO:0042832) | 2.51719606 |
| 89 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.51701602 |
| 90 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.51274327 |
| 91 | B cell mediated immunity (GO:0019724) | 2.50642160 |
| 92 | programmed necrotic cell death (GO:0097300) | 2.49804421 |
| 93 | regulation of interferon-alpha production (GO:0032647) | 2.49497365 |
| 94 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.48899553 |
| 95 | cellular response to interleukin-15 (GO:0071350) | 2.48247912 |
| 96 | regulation of necroptotic process (GO:0060544) | 2.48209594 |
| 97 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.48061911 |
| 98 | T cell selection (GO:0045058) | 2.47387203 |
| 99 | negative regulation of B cell proliferation (GO:0030889) | 2.46902320 |
| 100 | cellular response to zinc ion (GO:0071294) | 2.46095536 |
| 101 | T-helper 1 type immune response (GO:0042088) | 2.45392498 |
| 102 | ribosomal small subunit biogenesis (GO:0042274) | 2.45143217 |
| 103 | T cell migration (GO:0072678) | 2.44392837 |
| 104 | regulation of T-helper 1 type immune response (GO:0002825) | 2.44201772 |
| 105 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.43918670 |
| 106 | cytokine biosynthetic process (GO:0042089) | 2.42776685 |
| 107 | regulation of tolerance induction (GO:0002643) | 2.42591940 |
| 108 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.40974465 |
| 109 | positive regulation of B cell mediated immunity (GO:0002714) | 2.40974465 |
| 110 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.40200874 |
| 111 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.39807494 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 2.39116106 |
| 113 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.37091061 |
| 114 | negative regulation of T cell mediated immunity (GO:0002710) | 2.36809906 |
| 115 | monocyte chemotaxis (GO:0002548) | 2.36364717 |
| 116 | regulation of T cell chemotaxis (GO:0010819) | 2.35909420 |
| 117 | positive regulation of T cell chemotaxis (GO:0010820) | 2.35909420 |
| 118 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.35800628 |
| 119 | protein localization to endoplasmic reticulum (GO:0070972) | 2.35232939 |
| 120 | T cell apoptotic process (GO:0070231) | 2.35013850 |
| 121 | ER overload response (GO:0006983) | 2.34976837 |
| 122 | leukocyte cell-cell adhesion (GO:0007159) | 2.34674520 |
| 123 | positive regulation of interleukin-17 production (GO:0032740) | 2.34576694 |
| 124 | regulation of T-helper cell differentiation (GO:0045622) | 2.34292296 |
| 125 | tolerance induction (GO:0002507) | 2.33814827 |
| 126 | establishment of endothelial barrier (GO:0061028) | 2.33722840 |
| 127 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.33582420 |
| 128 | regulation of protein heterodimerization activity (GO:0043497) | 2.32944269 |
| 129 | T cell activation involved in immune response (GO:0002286) | 2.32738310 |
| 130 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.31745810 |
| 131 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.31725043 |
| 132 | negative regulation of viral genome replication (GO:0045071) | 2.31703510 |
| 133 | negative regulation of stress fiber assembly (GO:0051497) | 2.31617951 |
| 134 | ribosome assembly (GO:0042255) | 2.31116859 |
| 135 | regulation of B cell differentiation (GO:0045577) | 2.30229393 |
| 136 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.29888771 |
| 137 | necrotic cell death (GO:0070265) | 2.28957750 |
| 138 | detection of other organism (GO:0098543) | 2.25168262 |
| 139 | detection of bacterium (GO:0016045) | 2.25076787 |
| 140 | wound healing, spreading of epidermal cells (GO:0035313) | 2.23683233 |
| 141 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.22850968 |
| 142 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.22850968 |
| 143 | modulation by symbiont of host immune response (GO:0052553) | 2.22850968 |
| 144 | positive regulation by symbiont of host defense response (GO:0052509) | 2.22850968 |
| 145 | modulation by symbiont of host defense response (GO:0052031) | 2.22850968 |
| 146 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.22850968 |
| 147 | mammary gland epithelial cell proliferation (GO:0033598) | 2.21754478 |
| 148 | positive T cell selection (GO:0043368) | 2.21526293 |
| 149 | keratinocyte proliferation (GO:0043616) | 2.21141859 |
| 150 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.19604257 |
| 151 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.19501799 |
| 152 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.18008400 |
| 153 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.17635981 |
| 154 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.17444365 |
| 155 | leukocyte degranulation (GO:0043299) | 2.15463945 |
| 156 | cytokine metabolic process (GO:0042107) | 2.15087019 |
| 157 | hypotonic response (GO:0006971) | 2.14700830 |
| 158 | organelle membrane fusion (GO:0090174) | 2.14609842 |
| 159 | regulation of thymocyte apoptotic process (GO:0070243) | 2.14171031 |
| 160 | DNA deamination (GO:0045006) | 2.12695850 |
| 161 | positive regulation of cell killing (GO:0031343) | 2.11831856 |
| 162 | lymph node development (GO:0048535) | 2.11442139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.70793437 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.36931208 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.73805147 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.69067225 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.61489344 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.58751659 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.33800311 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.16386423 |
| 9 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.08332893 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.03441992 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.88318488 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.75274886 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73241289 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.71855909 |
| 15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.66275856 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38353885 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38081841 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36368007 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29790416 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28496255 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.27454043 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.23541049 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.22601431 |
| 24 | * MYB_26560356_Chip-Seq_TH2_Human | 2.14618682 |
| 25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.08247265 |
| 26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01007156 |
| 27 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91758793 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89963030 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85892387 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.85455755 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.85067850 |
| 32 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81597816 |
| 33 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.81539219 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.80287376 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77393492 |
| 36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.76823902 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.76416531 |
| 38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.75302016 |
| 39 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.73932369 |
| 40 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.73309870 |
| 41 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.70044399 |
| 42 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.69983414 |
| 43 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66713095 |
| 44 | MYC_22102868_ChIP-Seq_BL_Human | 1.66023337 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64979078 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63344934 |
| 47 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.61913944 |
| 48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59897314 |
| 49 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56095886 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52465839 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50217067 |
| 52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49859179 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48357435 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48143733 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.47507576 |
| 56 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.47312598 |
| 57 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46585420 |
| 58 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.46170802 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45681213 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45082039 |
| 61 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44985287 |
| 62 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.42260834 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40844560 |
| 64 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.40583568 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40537002 |
| 66 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.38118237 |
| 67 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.37312410 |
| 68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.37034602 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34315702 |
| 70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34282040 |
| 71 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.31791632 |
| 72 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31187817 |
| 73 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30632809 |
| 74 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.29764625 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29489719 |
| 76 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29362348 |
| 77 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29197150 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28369783 |
| 79 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28344266 |
| 80 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28032289 |
| 81 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25109992 |
| 82 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25109992 |
| 83 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.25084580 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24916189 |
| 85 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.24244711 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20892322 |
| 87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20167384 |
| 88 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.19903748 |
| 89 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17429163 |
| 90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17417453 |
| 91 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.15594511 |
| 92 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.15329716 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14930792 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 1.14698682 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13709105 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13604204 |
| 97 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.13386891 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13075823 |
| 99 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11551048 |
| 100 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11135656 |
| 101 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.10831826 |
| 102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10262965 |
| 103 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.09512142 |
| 104 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09100678 |
| 105 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08164303 |
| 106 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.07851800 |
| 107 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07376966 |
| 108 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07268361 |
| 109 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.06879278 |
| 110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06829749 |
| 111 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05404826 |
| 112 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.04913119 |
| 113 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.04758766 |
| 114 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.04330769 |
| 115 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04265677 |
| 116 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.03030977 |
| 117 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01965481 |
| 118 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.01231421 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00074459 |
| 120 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98917934 |
| 121 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.97788741 |
| 122 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97747701 |
| 123 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.96291229 |
| 124 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94665196 |
| 125 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93757165 |
| 126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93073566 |
| 127 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.92806614 |
| 128 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92760982 |
| 129 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91507587 |
| 130 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91449559 |
| 131 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90853886 |
| 132 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90797428 |
| 133 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.89697257 |
| 134 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.89299908 |
| 135 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89110838 |
| 136 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.88837601 |
| 137 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.86420105 |
| 138 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.85951681 |
| 139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85527162 |
| 140 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85477213 |
| 141 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84434999 |
| 142 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.82861164 |
| 143 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.82765498 |
| 144 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.82298647 |
| 145 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.81636112 |
| 146 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79911446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.77002677 |
| 2 | MP0000685_abnormal_immune_system | 3.01071653 |
| 3 | MP0009785_altered_susceptibility_to | 2.99961732 |
| 4 | MP0005671_abnormal_response_to | 2.95090176 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.91335236 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.69469714 |
| 7 | MP0003436_decreased_susceptibility_to | 2.68169115 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.55520832 |
| 9 | MP0005387_immune_system_phenotype | 2.47214033 |
| 10 | MP0001790_abnormal_immune_system | 2.47214033 |
| 11 | MP0005025_abnormal_response_to | 2.32410631 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.30322095 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.28845685 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.27934855 |
| 15 | MP0001800_abnormal_humoral_immune | 2.26787466 |
| 16 | MP0002723_abnormal_immune_serum | 2.18246972 |
| 17 | MP0001819_abnormal_immune_cell | 2.14737306 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.14069866 |
| 19 | MP0002006_tumorigenesis | 2.14033651 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.13221054 |
| 21 | MP0002419_abnormal_innate_immunity | 2.06876169 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.05197489 |
| 23 | MP0002405_respiratory_system_inflammati | 2.01391413 |
| 24 | MP0003724_increased_susceptibility_to | 2.00029102 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.98723662 |
| 26 | MP0004272_abnormal_basement_membrane | 1.94409824 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.93000354 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.91633113 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.90014420 |
| 30 | MP0000858_altered_metastatic_potential | 1.86539602 |
| 31 | MP0006082_CNS_inflammation | 1.81957997 |
| 32 | MP0002398_abnormal_bone_marrow | 1.81037291 |
| 33 | MP0000490_abnormal_crypts_of | 1.77882600 |
| 34 | MP0010678_abnormal_skin_adnexa | 1.75431270 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.75158054 |
| 36 | MP0000716_abnormal_immune_system | 1.71084824 |
| 37 | MP0001348_abnormal_lacrimal_gland | 1.69616870 |
| 38 | MP0001873_stomach_inflammation | 1.67300518 |
| 39 | MP0003303_peritoneal_inflammation | 1.67253109 |
| 40 | MP0001853_heart_inflammation | 1.66049103 |
| 41 | MP0004947_skin_inflammation | 1.63562662 |
| 42 | MP0003866_abnormal_defecation | 1.62885935 |
| 43 | MP0005275_abnormal_skin_tensile | 1.61947532 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.61379652 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.60493143 |
| 46 | MP0006054_spinal_hemorrhage | 1.58227933 |
| 47 | MP0002060_abnormal_skin_morphology | 1.58122485 |
| 48 | MP0003693_abnormal_embryo_hatching | 1.57348287 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.57267910 |
| 50 | MP0003448_altered_tumor_morphology | 1.57010565 |
| 51 | MP0002796_impaired_skin_barrier | 1.55677657 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.55651051 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.53635045 |
| 54 | MP0005310_abnormal_salivary_gland | 1.52344555 |
| 55 | MP0002877_abnormal_melanocyte_morpholog | 1.50489376 |
| 56 | MP0001216_abnormal_epidermal_layer | 1.46475699 |
| 57 | MP0002722_abnormal_immune_system | 1.46097195 |
| 58 | MP0008007_abnormal_cellular_replicative | 1.44951894 |
| 59 | MP0002429_abnormal_blood_cell | 1.42733890 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.38983992 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.38981336 |
| 62 | MP0001851_eye_inflammation | 1.38664988 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.37898450 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.37898450 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.32524116 |
| 66 | MP0005164_abnormal_response_to | 1.32052507 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.27601047 |
| 68 | MP0003252_abnormal_bile_duct | 1.27585936 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 1.26899703 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.24729824 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.24197242 |
| 72 | MP0004510_myositis | 1.23579408 |
| 73 | MP0000383_abnormal_hair_follicle | 1.15749426 |
| 74 | MP0002132_abnormal_respiratory_system | 1.14911106 |
| 75 | MP0008004_abnormal_stomach_pH | 1.13373959 |
| 76 | MP0005166_decreased_susceptibility_to | 1.12711486 |
| 77 | MP0009278_abnormal_bone_marrow | 1.12659435 |
| 78 | MP0002277_abnormal_respiratory_mucosa | 1.12151838 |
| 79 | MP0005023_abnormal_wound_healing | 1.09448526 |
| 80 | MP0002933_joint_inflammation | 1.07935398 |
| 81 | MP0010307_abnormal_tumor_latency | 1.07918735 |
| 82 | MP0002163_abnormal_gland_morphology | 1.07867118 |
| 83 | MP0003786_premature_aging | 1.06187844 |
| 84 | MP0004381_abnormal_hair_follicle | 1.06037874 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 1.05969599 |
| 86 | MP0008057_abnormal_DNA_replication | 1.04331643 |
| 87 | MP0008469_abnormal_protein_level | 1.03642792 |
| 88 | MP0009764_decreased_sensitivity_to | 1.03145133 |
| 89 | MP0005501_abnormal_skin_physiology | 1.03011240 |
| 90 | MP0003091_abnormal_cell_migration | 1.01997658 |
| 91 | MP0003077_abnormal_cell_cycle | 1.01938159 |
| 92 | MP0002009_preneoplasia | 0.99622836 |
| 93 | MP0005076_abnormal_cell_differentiation | 0.97461269 |
| 94 | MP0002019_abnormal_tumor_incidence | 0.97334596 |
| 95 | MP0005165_increased_susceptibility_to | 0.96742193 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.95367061 |
| 97 | MP0004957_abnormal_blastocyst_morpholog | 0.94917633 |
| 98 | MP0000013_abnormal_adipose_tissue | 0.91893881 |
| 99 | MP0003943_abnormal_hepatobiliary_system | 0.90398304 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.90394690 |
| 101 | MP0005058_abnormal_lysosome_morphology | 0.90340711 |
| 102 | MP0008260_abnormal_autophagy | 0.90185836 |
| 103 | MP0004484_altered_response_of | 0.89434888 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.87387496 |
| 105 | MP0000371_diluted_coat_color | 0.83420782 |
| 106 | MP0010771_integument_phenotype | 0.82121752 |
| 107 | MP0005390_skeleton_phenotype | 0.79478021 |
| 108 | MP0000377_abnormal_hair_follicle | 0.79368443 |
| 109 | MP0000627_abnormal_mammary_gland | 0.79168701 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.78538328 |
| 111 | MP0000343_altered_response_to | 0.78511131 |
| 112 | MP0001191_abnormal_skin_condition | 0.78252558 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.77844369 |
| 114 | MP0000762_abnormal_tongue_morphology | 0.75328392 |
| 115 | MP0005360_urolithiasis | 0.74870939 |
| 116 | MP0009931_abnormal_skin_appearance | 0.74590425 |
| 117 | MP0003828_pulmonary_edema | 0.73636797 |
| 118 | MP0000613_abnormal_salivary_gland | 0.73179632 |
| 119 | MP0000477_abnormal_intestine_morphology | 0.69710060 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.68850114 |
| 121 | MP0000015_abnormal_ear_pigmentation | 0.68504645 |
| 122 | MP0009379_abnormal_foot_pigmentation | 0.68430922 |
| 123 | MP0003941_abnormal_skin_development | 0.67242879 |
| 124 | MP0002254_reproductive_system_inflammat | 0.66973798 |
| 125 | MP0005084_abnormal_gallbladder_morpholo | 0.65958879 |
| 126 | MP0010094_abnormal_chromosome_stability | 0.65468411 |
| 127 | MP0003795_abnormal_bone_structure | 0.65206702 |
| 128 | MP0001663_abnormal_digestive_system | 0.64885778 |
| 129 | MP0001881_abnormal_mammary_gland | 0.64764346 |
| 130 | MP0001346_abnormal_lacrimal_gland | 0.64754343 |
| 131 | MP0000313_abnormal_cell_death | 0.63661707 |
| 132 | MP0001879_abnormal_lymphatic_vessel | 0.63437601 |
| 133 | MP0002095_abnormal_skin_pigmentation | 0.62868601 |
| 134 | MP0000249_abnormal_blood_vessel | 0.62353423 |
| 135 | MP0008438_abnormal_cutaneous_collagen | 0.62111335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.44764030 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.34948905 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.33439617 |
| 4 | Myositis (HP:0100614) | 4.27843927 |
| 5 | Milia (HP:0001056) | 3.81873787 |
| 6 | Thrombocytosis (HP:0001894) | 3.77692094 |
| 7 | Orchitis (HP:0100796) | 3.68929245 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.68825858 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 3.67718168 |
| 10 | Optic neuritis (HP:0100653) | 3.67718168 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.64068641 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 3.58596873 |
| 13 | Onycholysis (HP:0001806) | 3.56481354 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.32991368 |
| 15 | Abnormality of T cell number (HP:0011839) | 3.14986302 |
| 16 | Increased IgM level (HP:0003496) | 3.09276954 |
| 17 | Plantar hyperkeratosis (HP:0007556) | 3.06933814 |
| 18 | Recurrent viral infections (HP:0004429) | 3.06272385 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.05053046 |
| 20 | Alopecia of scalp (HP:0002293) | 3.04699153 |
| 21 | Abnormality of T cell physiology (HP:0011840) | 3.00029909 |
| 22 | Abnormality of T cells (HP:0002843) | 2.97858358 |
| 23 | Glucose intolerance (HP:0000833) | 2.93871141 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.92464937 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 2.91276309 |
| 26 | Stomatitis (HP:0010280) | 2.89104479 |
| 27 | T lymphocytopenia (HP:0005403) | 2.88887254 |
| 28 | Chronic otitis media (HP:0000389) | 2.86051868 |
| 29 | Reticulocytopenia (HP:0001896) | 2.81688384 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80676775 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80676775 |
| 32 | Autoimmune hemolytic anemia (HP:0001890) | 2.79606789 |
| 33 | Obstructive lung disease (HP:0006536) | 2.78947806 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.78947806 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.78197178 |
| 36 | Recurrent bronchitis (HP:0002837) | 2.75326179 |
| 37 | Vasculitis (HP:0002633) | 2.73550923 |
| 38 | Aortic dissection (HP:0002647) | 2.72972539 |
| 39 | Atrophic scars (HP:0001075) | 2.70432696 |
| 40 | Pustule (HP:0200039) | 2.69703626 |
| 41 | Fragile nails (HP:0001808) | 2.67415525 |
| 42 | IgM deficiency (HP:0002850) | 2.66516632 |
| 43 | Malnutrition (HP:0004395) | 2.63149540 |
| 44 | Lip pit (HP:0100267) | 2.62050971 |
| 45 | Recurrent skin infections (HP:0001581) | 2.61430357 |
| 46 | Chronic diarrhea (HP:0002028) | 2.60801751 |
| 47 | Interstitial pulmonary disease (HP:0006530) | 2.60566426 |
| 48 | Eosinophilia (HP:0001880) | 2.59951253 |
| 49 | Subacute progressive viral hepatitis (HP:0006572) | 2.55852486 |
| 50 | Spondylolisthesis (HP:0003302) | 2.55346598 |
| 51 | Leukocytosis (HP:0001974) | 2.53774029 |
| 52 | Periodontitis (HP:0000704) | 2.51404330 |
| 53 | Nasal polyposis (HP:0100582) | 2.51258212 |
| 54 | Hypoplasia of the uterus (HP:0000013) | 2.49092956 |
| 55 | IgA deficiency (HP:0002720) | 2.48501904 |
| 56 | Arterial thrombosis (HP:0004420) | 2.48175221 |
| 57 | Thick nail (HP:0001805) | 2.44991375 |
| 58 | Granulocytopenia (HP:0001913) | 2.43320912 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.42238384 |
| 60 | IgG deficiency (HP:0004315) | 2.41673752 |
| 61 | Cheilitis (HP:0100825) | 2.40495172 |
| 62 | Meningitis (HP:0001287) | 2.40291987 |
| 63 | Palpitations (HP:0001962) | 2.40192028 |
| 64 | Gingivitis (HP:0000230) | 2.39526901 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.39442007 |
| 66 | Abnormality of eosinophils (HP:0001879) | 2.39106408 |
| 67 | Petechiae (HP:0000967) | 2.35201681 |
| 68 | Severe combined immunodeficiency (HP:0004430) | 2.34442642 |
| 69 | Palmoplantar hyperkeratosis (HP:0000972) | 2.32265854 |
| 70 | Nail dystrophy (HP:0008404) | 2.31603485 |
| 71 | Hemoptysis (HP:0002105) | 2.29723419 |
| 72 | Syringomyelia (HP:0003396) | 2.24434853 |
| 73 | Spinal cord lesions (HP:0100561) | 2.24434853 |
| 74 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.23529807 |
| 75 | Aplastic anemia (HP:0001915) | 2.22157290 |
| 76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20962905 |
| 77 | Panhypogammaglobulinemia (HP:0003139) | 2.16878317 |
| 78 | Encephalitis (HP:0002383) | 2.15882540 |
| 79 | Palmar hyperkeratosis (HP:0010765) | 2.15646280 |
| 80 | Micronodular cirrhosis (HP:0001413) | 2.15505215 |
| 81 | Abnormality of the nasal mucosa (HP:0000433) | 2.15116584 |
| 82 | Lymphopenia (HP:0001888) | 2.14979778 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.14423941 |
| 84 | Osteolytic defects of the hand bones (HP:0009699) | 2.14423941 |
| 85 | Metaphyseal dysplasia (HP:0100255) | 2.13785895 |
| 86 | Basal ganglia calcification (HP:0002135) | 2.12611053 |
| 87 | Combined immunodeficiency (HP:0005387) | 2.11664512 |
| 88 | Cellulitis (HP:0100658) | 2.11554001 |
| 89 | Vertebral compression fractures (HP:0002953) | 2.09472485 |
| 90 | Thyroiditis (HP:0100646) | 2.08737801 |
| 91 | Hypoproteinemia (HP:0003075) | 2.07091443 |
| 92 | Sparse eyelashes (HP:0000653) | 2.06915624 |
| 93 | Inflammation of the large intestine (HP:0002037) | 2.06829268 |
| 94 | Gastrointestinal infarctions (HP:0005244) | 2.06578544 |
| 95 | Entropion (HP:0000621) | 2.05551332 |
| 96 | Premature rupture of membranes (HP:0001788) | 2.04041388 |
| 97 | Abnormality of B cell number (HP:0010975) | 2.03544865 |
| 98 | B lymphocytopenia (HP:0010976) | 2.03544865 |
| 99 | 11 pairs of ribs (HP:0000878) | 2.02302971 |
| 100 | Abnormal pancreas size (HP:0012094) | 2.01926411 |
| 101 | Xerostomia (HP:0000217) | 2.01765591 |
| 102 | Keratoconjunctivitis sicca (HP:0001097) | 2.00564513 |
| 103 | Spontaneous hematomas (HP:0007420) | 1.99952429 |
| 104 | Gastrointestinal inflammation (HP:0004386) | 1.98121218 |
| 105 | Abnormal glucose tolerance (HP:0001952) | 1.97779749 |
| 106 | Curly hair (HP:0002212) | 1.96995381 |
| 107 | Abnormal hair laboratory examination (HP:0003328) | 1.95593229 |
| 108 | Increased IgE level (HP:0003212) | 1.95163327 |
| 109 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.94240401 |
| 110 | Pallor (HP:0000980) | 1.94086024 |
| 111 | Abnormality of oral frenula (HP:0000190) | 1.92345711 |
| 112 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.92178370 |
| 113 | Abnormality of nail color (HP:0100643) | 1.92053683 |
| 114 | Fatigue (HP:0012378) | 1.91134449 |
| 115 | Abnormal blistering of the skin (HP:0008066) | 1.91133896 |
| 116 | Arterial tortuosity (HP:0005116) | 1.89705028 |
| 117 | Prostate neoplasm (HP:0100787) | 1.89059860 |
| 118 | Recurrent pneumonia (HP:0006532) | 1.88459814 |
| 119 | Erythema (HP:0010783) | 1.88082560 |
| 120 | Keratoconjunctivitis (HP:0001096) | 1.87913756 |
| 121 | Osteomyelitis (HP:0002754) | 1.87832863 |
| 122 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.86426435 |
| 123 | Woolly hair (HP:0002224) | 1.85898206 |
| 124 | Urticaria (HP:0001025) | 1.83684131 |
| 125 | Acute myeloid leukemia (HP:0004808) | 1.82767690 |
| 126 | Ectropion (HP:0000656) | 1.82722431 |
| 127 | Amaurosis fugax (HP:0100576) | 1.82563006 |
| 128 | Skin ulcer (HP:0200042) | 1.81550309 |
| 129 | Lymphoma (HP:0002665) | 1.81313483 |
| 130 | Poor head control (HP:0002421) | 1.80936384 |
| 131 | Abnormal albumin level (HP:0012116) | 1.80448132 |
| 132 | Hypoalbuminemia (HP:0003073) | 1.80448132 |
| 133 | Aortic aneurysm (HP:0004942) | 1.78964600 |
| 134 | Chest pain (HP:0100749) | 1.78402072 |
| 135 | Aplasia cutis congenita (HP:0001057) | 1.78265632 |
| 136 | Increased density of long bones (HP:0006392) | 1.76450325 |
| 137 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.76383971 |
| 138 | Oral leukoplakia (HP:0002745) | 1.76273433 |
| 139 | Peritonitis (HP:0002586) | 1.76178159 |
| 140 | Abnormality of the prostate (HP:0008775) | 1.76162704 |
| 141 | Abnormal number of erythroid precursors (HP:0012131) | 1.76091979 |
| 142 | Verrucae (HP:0200043) | 1.75902742 |
| 143 | Papilloma (HP:0012740) | 1.75902742 |
| 144 | Viral hepatitis (HP:0006562) | 1.75817387 |
| 145 | Absent frontal sinuses (HP:0002688) | 1.75810920 |
| 146 | Alveolar cell carcinoma (HP:0006519) | 1.75476944 |
| 147 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.75401914 |
| 148 | Villous atrophy (HP:0011473) | 1.75401914 |
| 149 | Joint swelling (HP:0001386) | 1.75380553 |
| 150 | Type I transferrin isoform profile (HP:0003642) | 1.75113044 |
| 151 | Recurrent lower respiratory tract infections (HP:0002783) | 1.73968127 |
| 152 | Albinism (HP:0001022) | 1.73528090 |
| 153 | Fragile skin (HP:0001030) | 1.71083548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.39941089 |
| 2 | JAK3 | 2.87643941 |
| 3 | PIM2 | 2.85003768 |
| 4 | MAP4K1 | 2.76174079 |
| 5 | TXK | 2.62893206 |
| 6 | BLK | 2.58323982 |
| 7 | NME2 | 2.45558261 |
| 8 | IRAK3 | 2.40434692 |
| 9 | TBK1 | 2.38913622 |
| 10 | TRIM28 | 2.26221946 |
| 11 | IRAK4 | 2.22778460 |
| 12 | IKBKB | 2.17608534 |
| 13 | MST4 | 2.12754880 |
| 14 | ZAP70 | 2.12434759 |
| 15 | STK24 | 1.96174695 |
| 16 | TYK2 | 1.95994590 |
| 17 | TESK1 | 1.91050914 |
| 18 | IKBKE | 1.89114662 |
| 19 | EPHA2 | 1.83627216 |
| 20 | TEC | 1.72126644 |
| 21 | CHUK | 1.64490469 |
| 22 | KIT | 1.63041608 |
| 23 | RPS6KA4 | 1.60377399 |
| 24 | BCR | 1.57968651 |
| 25 | MET | 1.55584528 |
| 26 | LATS1 | 1.54758489 |
| 27 | NLK | 1.53830900 |
| 28 | NEK9 | 1.53094645 |
| 29 | BTK | 1.48626908 |
| 30 | FLT3 | 1.43746413 |
| 31 | STK10 | 1.40134585 |
| 32 | STK38L | 1.36697183 |
| 33 | PIM1 | 1.35578779 |
| 34 | ITK | 1.34318966 |
| 35 | MAP3K2 | 1.30316497 |
| 36 | KDR | 1.28528009 |
| 37 | JAK1 | 1.28227284 |
| 38 | TESK2 | 1.27928301 |
| 39 | PBK | 1.27336468 |
| 40 | TGFBR1 | 1.24494503 |
| 41 | MAP3K3 | 1.23023803 |
| 42 | LRRK2 | 1.22104449 |
| 43 | ERBB3 | 1.19866651 |
| 44 | STK3 | 1.15716581 |
| 45 | PASK | 1.15377727 |
| 46 | EPHA3 | 1.15343784 |
| 47 | MAP2K3 | 1.13137295 |
| 48 | FRK | 1.09929027 |
| 49 | NUAK1 | 1.07460931 |
| 50 | LCK | 1.05856341 |
| 51 | SYK | 1.03004556 |
| 52 | TAOK3 | 1.02596001 |
| 53 | CSK | 1.01359353 |
| 54 | STK39 | 1.01067883 |
| 55 | TRPM7 | 1.01040625 |
| 56 | ERN1 | 0.96416384 |
| 57 | ACVR1B | 0.94483154 |
| 58 | FGFR4 | 0.92637611 |
| 59 | EIF2AK3 | 0.92034984 |
| 60 | PAK4 | 0.91971113 |
| 61 | PTK6 | 0.87931744 |
| 62 | HCK | 0.87914260 |
| 63 | FGFR3 | 0.87025689 |
| 64 | PDK2 | 0.83908696 |
| 65 | AKT3 | 0.83387428 |
| 66 | TTN | 0.82271928 |
| 67 | STK16 | 0.82110737 |
| 68 | LYN | 0.80574810 |
| 69 | BMPR2 | 0.79513845 |
| 70 | CSF1R | 0.79069277 |
| 71 | RPS6KB2 | 0.78734099 |
| 72 | PTK2 | 0.78590657 |
| 73 | PIK3CG | 0.78138862 |
| 74 | PRKCI | 0.77647856 |
| 75 | MELK | 0.77582180 |
| 76 | LMTK2 | 0.77439486 |
| 77 | STK4 | 0.76885506 |
| 78 | FER | 0.76541278 |
| 79 | EIF2AK2 | 0.74987061 |
| 80 | EEF2K | 0.72921541 |
| 81 | EPHB1 | 0.72204684 |
| 82 | IRAK1 | 0.71101177 |
| 83 | MAP3K11 | 0.68798803 |
| 84 | PRKCQ | 0.68691105 |
| 85 | TAF1 | 0.67045566 |
| 86 | TGFBR2 | 0.64310748 |
| 87 | EIF2AK1 | 0.63638606 |
| 88 | MAPKAPK2 | 0.63121993 |
| 89 | SCYL2 | 0.59812701 |
| 90 | ZAK | 0.59696110 |
| 91 | PRKG2 | 0.58697772 |
| 92 | OXSR1 | 0.58411011 |
| 93 | LIMK1 | 0.58410001 |
| 94 | MAP3K12 | 0.58394796 |
| 95 | MAP4K2 | 0.58208601 |
| 96 | SIK3 | 0.56699437 |
| 97 | MYLK | 0.56578461 |
| 98 | MST1R | 0.56227159 |
| 99 | STK38 | 0.55308239 |
| 100 | BMPR1B | 0.54216903 |
| 101 | TNIK | 0.53572127 |
| 102 | SRPK1 | 0.53267182 |
| 103 | ADRBK1 | 0.53150761 |
| 104 | MAP3K8 | 0.52940615 |
| 105 | MARK3 | 0.52618757 |
| 106 | PKN2 | 0.52070784 |
| 107 | MAP3K13 | 0.51842451 |
| 108 | MAP2K2 | 0.51814637 |
| 109 | BUB1 | 0.50603976 |
| 110 | ERBB4 | 0.49616782 |
| 111 | AURKB | 0.48658524 |
| 112 | DYRK1B | 0.48394453 |
| 113 | RIPK4 | 0.47804374 |
| 114 | GRK1 | 0.47060069 |
| 115 | PLK4 | 0.46772518 |
| 116 | ABL2 | 0.46288574 |
| 117 | DYRK3 | 0.45917350 |
| 118 | PIK3CA | 0.45694339 |
| 119 | JAK2 | 0.45128825 |
| 120 | RIPK1 | 0.44533196 |
| 121 | BRSK2 | 0.43657115 |
| 122 | DAPK1 | 0.43372776 |
| 123 | TLK1 | 0.43170513 |
| 124 | GRK6 | 0.43069744 |
| 125 | ABL1 | 0.42334752 |
| 126 | RPS6KA5 | 0.41724662 |
| 127 | CDK6 | 0.40965557 |
| 128 | ILK | 0.39697317 |
| 129 | MAP2K6 | 0.39182736 |
| 130 | KSR1 | 0.37990460 |
| 131 | ARAF | 0.36608493 |
| 132 | VRK2 | 0.36511179 |
| 133 | GRK7 | 0.33664010 |
| 134 | HIPK2 | 0.33090832 |
| 135 | EGFR | 0.32376871 |
| 136 | IGF1R | 0.30408876 |
| 137 | PTK2B | 0.29891690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 2.81265176 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.60806250 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.27978327 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.26131937 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.25270078 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.18395328 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.18190502 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.12748482 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.06425886 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.05596703 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.86629392 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.81522525 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 1.74516083 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74178010 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.70902001 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69062457 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67976145 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.67435328 |
| 19 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.61754148 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59302815 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.55747101 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.55055709 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.53540682 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.53123246 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.52304854 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.51894471 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47275208 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44882968 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40359230 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.37439083 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.36441104 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.36148891 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.34907603 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33495021 |
| 35 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.32370866 |
| 36 | Protein export_Homo sapiens_hsa03060 | 1.29167258 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.29085282 |
| 38 | DNA replication_Homo sapiens_hsa03030 | 1.25354570 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21192962 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.17951777 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.17829361 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.12017947 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11650172 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.10717578 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.10688728 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09716535 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06083350 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05803085 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02133141 |
| 50 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97250069 |
| 51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.96505373 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.96264388 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94359397 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93130452 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92459087 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91550170 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.90986576 |
| 58 | Mismatch repair_Homo sapiens_hsa03430 | 0.90827544 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88964451 |
| 60 | Base excision repair_Homo sapiens_hsa03410 | 0.88160072 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87973425 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.85773705 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85664618 |
| 64 | Spliceosome_Homo sapiens_hsa03040 | 0.82095687 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.81657293 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81444181 |
| 67 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.81152110 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80285384 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75740111 |
| 70 | Cell cycle_Homo sapiens_hsa04110 | 0.74014032 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73400869 |
| 72 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.73267026 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.72399011 |
| 74 | RNA polymerase_Homo sapiens_hsa03020 | 0.71789250 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.70145502 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.69617117 |
| 77 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.66194345 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66125058 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62722036 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62257243 |
| 81 | RNA transport_Homo sapiens_hsa03013 | 0.62171066 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61196253 |
| 83 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61155661 |
| 84 | Adherens junction_Homo sapiens_hsa04520 | 0.61120508 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.60731819 |
| 86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59565137 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58817834 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.58747057 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56619941 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56376547 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55876759 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55793209 |
| 93 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53952790 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53341148 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53147137 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52017511 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51185043 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51042885 |
| 99 | RNA degradation_Homo sapiens_hsa03018 | 0.50040419 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49661466 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49552855 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49287947 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48820149 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48541541 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47778018 |
| 106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46708645 |
| 107 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45923147 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44717964 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.44152257 |
| 110 | Pathways in cancer_Homo sapiens_hsa05200 | 0.43724049 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43479060 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43105811 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42709311 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.41686396 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41432155 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40881279 |
| 117 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.40793156 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40282713 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.40241687 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39709999 |
| 121 | Basal transcription factors_Homo sapiens_hsa03022 | 0.39056600 |
| 122 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.39045186 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.38248717 |
| 124 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.37933018 |

